Global Muckle Wells Syndrome Market ANALYSE DE LA TAILLE ET DU PARTAGE - TENDANCES DE CROISSANCE ET PRÉVISIONS (2023 - 2030)

Global Muckle Wells Syndrome Market is Segmented By Disease Type(Classical MWS, MWS with amyloidosis, MWS without amyloidosis, Overlap MWS, Others), By Treatment Type(Anti-inflammatory drugs, Immunosuppressants, Biologics, JAK inhibitors, Corticosteroids, Analgesics, Others), By Route of Administration (Oral, Injectable, Topical, Others), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD million) for the above-mentioned segments.

Global Muckle Wells Syndrome Market Leaders

  • AbbVie
  • Johnson et Johnson
  • Pfizer, Merck
  • Sanofi
  • Celgène
*Disclaimer: Major players are listed in no particular order.

Global Muckle Wells Syndrome Market - Company List

  • Novartis
  • AbbVie
  • Johnson et Johnson
  • Pfizer, Merck
  • Sanofi
  • Celgène
  • Amgen
  • Eli Lilly
  • Les sciences de Galaad
  • Biogène
  • Bayer
  • Boehringer Ingelheim
  • AstraZeneca
  • Bristol-Myers Squibb
  • Astellas Pharma
  • Daiichi Sankyo
  • Eisai
  • Takeda pharmaceutique
  • Ono Pharmaceutique